The Safety of Nafamostat Mesylate for Patients With High Risk Bleeding Undergoing Hemodialysis: A Pilot Study
NCT05874674
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Dialysis; Complications
Bleeding
Interventions
DRUG:
Nafamostat Mesylate
Sponsor
Wonju Severance Christian Hospital